Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|July 4, 2001
High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myelomaP C Huijgens, H M Dekker-Van Roessel, A R Jonkhoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual peopleA W F T Toorians, M C L G D Thomassen, S Zweegman, et al.
Leukemia|January 17, 2003
Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cellsT Netelenbos, J van den Born, F L Kessler, et al.
Bone Marrow Transplantation|July 30, 2013
Nailfold capillary abnormalities in sclerodermatous chronic GVHDH M A Hofstee, T T de Waal, S Zweegman, et al.
Psycho-Oncology|March 7, 2017
Shared decision-making and providing information among newly diagnosed patients with hematological malignancies and their informal caregivers: Not "one-size-fits-all"J A J Rood, I H Nauta, B I Witte, et al.
Bone Marrow Transplantation|August 1, 1996
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
International Journal of Laboratory Hematology|April 5, 2012
Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemiaM Terwijn, A Kelder, A N Snel, et al.
Bone Marrow Transplantation|August 4, 2015
Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysisS Slot, K Smits, N W C J van de Donk, et al.
EJNMMI Research|June 2, 2016
(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myelomaJ C Regelink, P G Raijmakers, N Bravenboer, et al.
Bone Marrow Transplantation|April 20, 2010
Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experienceM C Minnema, S van Dorp, N W C J van de Donk, et al.
Pageof 5